Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Albendazole Tablets USP, 200 mg. The approved ANDA is therapeutically equivalent to the reference liste
![Alembic Pharmaceuticals receives USFDA final approval for Albendazole Tablets](https://img.easybranches.com/uploads/news/2024/09/alembic-pharmaceuticals-receives-usfda-final-approval-for-albendazole-tablets.jpg)